Scholarlink

<p>Peritoneal dissemination is the major cause of mortality in epithelial ovarian cancer (EOC) and requires tumor cells to survive in a detached state by evading anoikis. However, the molecular mechanisms supporting anchorage-independent survival remain poorly defined. Here, we identify glutamate dehydrogenase 1 (GLUD1) as a key regulator of anoikis resistance and metastatic progression in EOC. GLUD1 expression was elevated in metastatic EOC tissues and associated with unfavorable clinical outcomes. Loss of GLUD1 impaired anoikis resistance and reduced metastatic capacity of ovarian cancer cells in vitro, while markedly suppressing peritoneal dissemination and prolonging survival in vivo. Mechanistically, GLUD1 was found to interact with a key protein ARAF, the A-Raf proto-oncogene. By limiting ubiquitin–proteasome-mediated degradation of ARAF, GLUD1 exerted a non-enzymatic function that stabilized ARAF protein levels and sustained MEK/ERK signaling.</p><p>Together, these findings reveal a non-canonical role of GLUD1 in regulating protein stability and identify the GLUD1–ARAF axis as a critical mechanism supporting anchorage-independent survival during peritoneal dissemination of EOC.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

GLUD1 supports ovarian cancer progression by counteracting anoikis via ARAF/MEK/ERK signaling

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月5日

查看全文
  • Huolun Feng,
  • Yanzhen Chen,
  • Geyan Wu,
  • Zhentao Zhang,
  • Hongkun Lai,
  • Changnian Yang,
  • Shaofen Zhang,
  • Yongqing Lin,
  • Yingqi Liu,
  • Haiyan Ye,
  • Shanshan Wu,
  • Lixue Cao

摘要

Peritoneal dissemination is the major cause of mortality in epithelial ovarian cancer (EOC) and requires tumor cells to survive in a detached state by evading anoikis. However, the molecular mechanisms supporting anchorage-independent survival remain poorly defined. Here, we identify glutamate dehydrogenase 1 (GLUD1) as a key regulator of anoikis resistance and metastatic progression in EOC. GLUD1 expression was elevated in metastatic EOC tissues and associated with unfavorable clinical outcomes. Loss of GLUD1 impaired anoikis resistance and reduced metastatic capacity of ovarian cancer cells in vitro, while markedly suppressing peritoneal dissemination and prolonging survival in vivo. Mechanistically, GLUD1 was found to interact with a key protein ARAF, the A-Raf proto-oncogene. By limiting ubiquitin–proteasome-mediated degradation of ARAF, GLUD1 exerted a non-enzymatic function that stabilized ARAF protein levels and sustained MEK/ERK signaling.

Together, these findings reveal a non-canonical role of GLUD1 in regulating protein stability and identify the GLUD1–ARAF axis as a critical mechanism supporting anchorage-independent survival during peritoneal dissemination of EOC.